You are here

  • Home
  • Archive
  • Volume 69, Issue 11
  • Persistence of immunophenotypically aberrant CD34+ myeloid progenitors is frequent in bone marrow of patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms treated with hypomethylating agents

Article metrics

Article menu
Download PDFPDF
Original article
Persistence of immunophenotypically aberrant CD34+ myeloid progenitors is frequent in bone marrow of patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms treated with hypomethylating agents

 

Online download statistics by month:

Online download statistics by month: April 2016 to March 2024

AbstractFullPdf
Apr 20161802826
May 201684119
Jun 20164875
Jul 20162355
Aug 20162878
Sep 201620554
Oct 20164591832
Nov 20164501522
Dec 201698734
Jan 201718737
Feb 201713158
Mar 201712585
Apr 201712020
May 20176221
Jun 20176784
Jul 20177142
Aug 20177554
Sep 20177331
Oct 201710300
Nov 20178100
Dec 20176332
Jan 201820564
Feb 20189463
Mar 20189720
Apr 20187763
May 20187021
Jun 20187733
Jul 20186111
Aug 20185201
Sep 20185411
Oct 20185811
Nov 20182700
Dec 20185234
Jan 20193900
Feb 20193910
Mar 20193402
Apr 20194322
May 20193511
Jun 20192222
Jul 20192610
Aug 20192111
Sep 20194300
Oct 20192911
Nov 20192421
Dec 20192511
Jan 20202422
Feb 20204412
Mar 2020600
Apr 20201721
May 20202712
Jun 20203510
Jul 20202310
Aug 20202200
Sep 20202200
Oct 20202432
Nov 20203421
Dec 20203910
Jan 20212310
Feb 20213612
Mar 20212911
Apr 20211111
May 2021700
Jun 2021110
Jul 2021222
Aug 2021100
Sep 2021311
Oct 20212021
Nov 20212021
Dec 20213100
Jan 20222200
Feb 20221600
Mar 20226701
Apr 20221310
May 20228802
Jun 20225912
Jul 20223600
Aug 20227711
Sep 20226230
Oct 20228400
Nov 20222921
Dec 20222500
Jan 20232411
Feb 20236311
Mar 20231020
Apr 20231400
May 20231710
Jun 20231200
Jul 20231843
Aug 20231111
Sep 2023900
Oct 20231200
Nov 20233432
Dec 20232710
Jan 20241520
Feb 2024700
Mar 20242100
Total5410239246